24 May 2013
Keywords: Merck & Co, HIV eradication research, Academia, UNC, UCSF
Article | 12 July 2011
US drug giant Merck & Co (NYSE: MRK) says that its researchers will participate in two new collaborative efforts led ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 July 2011
11 July 2011
23 May 2013
© 2013 thepharmaletter.com